Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Research & Development (2020 - 2025)

Celularity has reported Research & Development over the past 6 years, most recently at $4.6 million for Q3 2025.

  • Quarterly results put Research & Development at $4.6 million for Q3 2025, up 17.45% from a year ago — trailing twelve months through Sep 2025 was $15.5 million (up 16.71% YoY), and the annual figure for FY2024 was $17.4 million, down 42.93%.
  • Research & Development for Q3 2025 was $4.6 million at Celularity, up from $3.4 million in the prior quarter.
  • Over the last five years, Research & Development for CELU hit a ceiling of $25.3 million in Q2 2022 and a floor of -$272000.0 in Q4 2023.
  • Median Research & Development over the past 5 years was $8.6 million (2023), compared with a mean of $11.9 million.
  • Biggest five-year swings in Research & Development: crashed 102.47% in 2023 and later surged 1507.35% in 2024.
  • Celularity's Research & Development stood at $24.7 million in 2021, then plummeted by 55.48% to $11.0 million in 2022, then tumbled by 102.47% to -$272000.0 in 2023, then surged by 1507.35% to $3.8 million in 2024, then rose by 20.11% to $4.6 million in 2025.
  • The last three reported values for Research & Development were $4.6 million (Q3 2025), $3.4 million (Q2 2025), and $3.7 million (Q1 2025) per Business Quant data.